JPRN-UMIN000004460已完成2 期
eoadjuvant chemotherapy and radiotherapy for operable breast cancer - Neo CR
Osaka Medical Center for Cancer and Cardiovascular Diseases0 个研究点目标入组 35 人开始时间: 2010年10月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) past history of any invasive malignancy within the previous 5 years 2) past history of breast cancer or synchronous bilateral breast cancer 3) past history of radiotherapy for ipsilateral breast 4) Suspicious of allergy for radiotherapy 5) Suspicious of allergy for paclitaxel, 5FU, epirubicin or cyclophosphamide 7) Patients during uncontrollable diabetes or psychologic disorder 8) Patients who have grade3-4 neuropathy 9) Pregnant or breast-feeding 10) Any reason the physician believes that the patient is not appropriate to participate in the study
研究者
相似试验
尚未招募
不适用
A study comprising of chemotherapy and radiotherapy before the surgery of locally advanced rectal cancer.CTRI/2019/08/020847AIIMS New Delhi
招募中
不适用
eoadjuvant chemoradiotherapy for clinical stageIV pancreatic cancer.pancreatic cancerJPRN-UMIN000006782Yokohama City University Gastroenterological Surgery30
已完成
不适用
eoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinomas or squamous cell carcinomas of the esophagusEsophageal cancerCancerISRCTN80832026Erasmus Medical Center, Department of Medical Oncology (Netherlands)350
尚未招募
不适用
eoadjuvant chemoradiotherapy vs. chemotherapy alone in locally advanced esophageal squamous cell carcinoma: randomized phase II studyNeoplasmsKCT0002181Seoul National University Hospital114
尚未招募
3 期
eoadjuvant chemoradioation for resectable, non-metastasized ductal adenocarcinoma of the pancreasC25.0Head of pancreasDRKS00003893niversitätsklinikum Hamburg-Eppendorf410